Bright Minds Biosciences

DRUG • NASDAQ

Bright Minds Biosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ian McDonald, with a market cap of $840.8M.

Market Cap$840.8M

CEOIan McDonald

CountryCanada

Healthcare

Biotechnology

Next EarningsMay 14, 2026 · in a monthQ2 2026

Income Statement Balance Sheet Cash Flow Business Segments

Financials

View all metrics

Revenue

Net Income

Operating Cash Flow

EPS (Diluted)

DRU

Bright Minds Biosciences FAQ

Common questions about Bright Minds Biosciences

Bright Minds Biosciences is scheduled to report earnings for Q2 2026 on May 14, 2026.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.